An Open-Label, Single-dose, Randomized, Five-Period Cross-over to Compare Pharmacokinetics Profiles of Z7200 and Symbicort Turbohaler, With and Without Charcoal Blockade in Healthy Volunteers

Trial Profile

An Open-Label, Single-dose, Randomized, Five-Period Cross-over to Compare Pharmacokinetics Profiles of Z7200 and Symbicort Turbohaler, With and Without Charcoal Blockade in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Mar 2015

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Sponsors Zambon SpA
  • Most Recent Events

    • 04 Mar 2015 Status changed from recruiting to completed, according to the ClinicalTrials.gov record.
    • 16 Dec 2014 Planned End Date changed from 1 Nov 2014 to 1 Jan 2015, according to the ClinicalTrials.gov record.
    • 16 Dec 2014 Planned primary completion date changed from 1 Nov 2014 to 1 Jan 2015, according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top